Health and Medicine
-
May 31, 2013
Chemical causes kidney failure in mosquitoes: study
Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE. -
May 30, 2013
Defense Department grant spurs nerve regeneration research
Vanderbilt investigators led by Wesley Thayer, M.D., Ph.D., assistant professor of Plastic Surgery and Orthopaedic Surgery and Rehabilitation, have been awarded a $1.1 million grant from the Department of Defense to develop a new surgical device that may help repair severed nerves. -
May 30, 2013
Study lays groundwork for rational T cell vaccine design
Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response. -
May 28, 2013
Vanderbilt physician says ugly plants worse for allergy patients
As allergy season rolls in for Middle Tennessee residents, a largely unknown adage rings true: the uglier a flower or weed, the more allergy-inducing its pollen tends to be. -
May 23, 2013
Blood test for autism could speed diagnosis
Vanderbilt University is part of a multi-site autism clinical study designed to evaluate the effectiveness of a blood test that aims to screen children for referral for autism spectrum disorder evaluation (ASD) earlier and more accurately. -
May 23, 2013
VICC hosts cancer researchers during annual retreat
The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center. -
May 16, 2013
Grant targets new therapies for Ebola, Marburg viruses
Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses.